PMC:7796052 / 12185-12391 JSONTXT

Annnotations TAB JSON ListView MergeView

{"target":"https://pubannotation.org/docs/sourcedb/PMC/sourceid/7796052","sourcedb":"PMC","sourceid":"7796052","source_url":"https://www.ncbi.nlm.nih.gov/pmc/7796052","text":"Concentrations necessary for the therapeutical benefit of raloxifene towards the BK B2 receptor are expected to be, at most, around 100 times higher, which is within the therapeutic window of the drug [44].","tracks":[{"project":"LitCovid-PubTator","denotations":[{"id":"314","span":{"begin":58,"end":68},"obj":"Chemical"}],"attributes":[{"id":"A314","pred":"tao:has_database_id","subj":"314","obj":"MESH:D020849"},{"subj":"314","pred":"source","obj":"LitCovid-PubTator"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}]},{"project":"LitCovid-sentences","denotations":[{"id":"T78","span":{"begin":0,"end":206},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"attributes":[{"subj":"T78","pred":"source","obj":"LitCovid-sentences"}]}],"config":{"attribute types":[{"pred":"source","value type":"selection","values":[{"id":"LitCovid-PubTator","color":"#9a93ec","default":true},{"id":"LitCovid-sentences","color":"#a5ec93"}]}]}}